Filter
1583
Text search:
drug
market
Featured
Recommendations
131
New Publications
465
Language
Document type
No document type
878
Studies & Reports
297
Guidelines
193
Strategic & Response Plan
87
Manuals
75
Fact sheets
22
Training Material
16
Situation Updates
7
Resource Platforms
5
Brochures
1
App
1
Infographics
1
Countries / Regions
India
80
Global
65
Kenya
61
Ethiopia
51
Uganda
48
Western and Central Europe
40
Ghana
37
Nigeria
36
Myanmar / Burma
33
Liberia
30
Bangladesh
30
Sierra Leone
29
Zambia
26
Malawi
26
South Africa
25
Africa
25
Nepal
21
Tanzania
21
Philippines
20
Rwanda
18
Ukraine
17
Latin America and the Carribbean
17
Congo, Democratic Republic of
16
Zimbabwe
15
Cambodia
14
Asia
13
Namibia
12
South–East Asia Region
12
Eastern Europe
12
Indonesia
10
Venezuela
10
Senegal
9
Syria
9
Guinea
8
Brazil
8
Botswana
8
Lesotho
8
Mozambique
7
Burkina Faso
6
Cameroon
6
Thailand
6
China
6
Albania
6
Russia
6
Haiti
5
Eswatini/ Swaziland
5
Eastern Europe and Central Asia
5
Vietnam
5
South Sudan
4
Sudan
4
Colombia
4
Sri Lanka
4
East and Southern Africa
4
West and Central Africa
4
USA
3
Germany
3
Benin
3
Peru
3
North Macedonia
3
Mexico
3
Middle East and North Africa
3
Laos
3
Timor Leste/ East Timor
3
Moldova
3
Georgia
3
Somalia
2
Pakistan
2
Jordan
2
Lebanon
2
Central African Republic
2
Argentina
2
Hungary
2
Libya
2
Western Pacific Region
2
Poland
2
Tajikistan
2
Iran
2
Morocco
1
Iraq
1
Afghanistan
1
Papua New Guinea
1
Switzerland
1
Serbia
1
Bolivia
1
Madagascar
1
Chile
1
Fiji
1
Bhutan
1
Palestine
1
North Korea
1
Italy
1
Canada
1
Qatar
1
Bulgaria
1
Estonia
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
652
Clinical Guidelines
101
Public Health
71
Key Resources
54
Pharmacy & Technologies
41
Women & Child Health
40
Capacity Building
13
Toolboxes
HIV
151
Mental Health
135
AMR
131
TB
104
Pharmacy
103
COVID-19
70
NTDs
41
Malaria
30
Planetary Health
28
Health Financing Toolbox
26
Conflict
25
Ebola & Marburg
23
Global Health Education
22
NCDs
22
Disability
18
Refugee
18
Caregiver
16
Rapid Response
13
Cholera
12
2.0 Rapid Response
7
Natural Hazards
6
Social Ethics
4
Polio
3
Specific Hazards
3
Technical Report
AIDS Medicines and diagnostics service
July 2015
A review of prospects for existing antibiotics ad new therapeutics
Nigeria Malaria Indicator Survey (NMIS) - Key Indicators 2021
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies for an HIV/AIDS program. Many of the suggested techniques described in this handbook are helpfu
...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot
...
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
In concordance with the global and WHO activities on ARC, the Ministry of Health and Family Welfare (MoHFW) in Bangladesh has come forward and initiative was taken to conduct program for containment of antimicrobial resistance in Bangladesh. Director, Disease Control and Line Director, Communicable
...
Menthol in tobacco products
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t
...
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘
...
The WHO Framework for the clinical evaluation of devices for male circumcision
outlines a multi-phase process to ensure the safety, efficacy, and acceptability of new devices, especially for use in resource-limited settings
Towards ending tuberculosis and multidrug-resistant tuberculosis.